Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

But sometimes, cell ... look for cancer cells. Doctors rely on various types of imaging technologies for viewing cancers inside the body. These techniques include MRI, which creates pictures ...

To overcome this hurdle, the researchers designed a multifunctional nanoplatform capable of reshaping the tumor microenvironment and enhancing the body's natural immune defense against cancer.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...

The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe Philadelphia ...

The basal state co-expresses both epithelial and mesenchymal programs and has a distinct epigenetic landscape with accessible chromatin across gene sets that mark cancer cell states with divergent ...

the drug has generate promising results in advanced non-small cell lung cancer (NSCLC). Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response ...